We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+12.53%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$3.25B
AUM Growth
+$307M
(+10%)
Cap. Flow
+$95.8M
Cap. Flow
% of AUM
2.95%
Top 10 Holdings %
Top 10 Hldgs %
41.75%
Holding
101
New
19
Increased
28
Reduced
23
Closed
18
Top Buys
| 1 |
Cigna
CI
|
+$68.6M |
| 2 |
ALLK
Allakos
ALLK
|
+$59.9M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$58.6M |
| 4 |
Fate Therapeutics
FATE
|
+$43.8M |
| 5 |
Replimune Group
REPL
|
+$38.4M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$60.7M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$56.5M |
| 3 |
Labcorp
LH
|
+$51.8M |
| 4 |
Insmed
INSM
|
+$48.1M |
| 5 |
Centene
CNC
|
+$39.7M |
Sector Composition
| 1 | Healthcare | 93.71% |
| 2 | Financials | 1.28% |
| 3 | Energy | 0.69% |
| 4 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NITE
26
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $42.5M | 1.31% |
2,080,846
+295,400
| +17% | +$6.06M |
|
27
Xeris Biopharma Holdings
XERS
$1.5B
| $42.4M | 1.3% |
2,412,640
-2
| -0% | -$43 |
|
28
eHealth
EHTH
$48.6M
| $41.6M | 1.28% |
1,472,595
+94,700
| +7% | +$2.51M |
|
|
HSKA
29
DELISTED
Heska Corp
HSKA
| $41M | 1.26% |
361,676
+6,900
| +2% | +$725K |
|
30
UnitedHealth
UNH
$380B
| $38.8M | 1.19% |
145,820
+2,800
| +2% | +$728K |
|
|
BLUE
31
DELISTED
bluebird bio
BLUE
| $36.8M | 1.13% |
19,462
-1,266
| -6% | -$2.62M |
|
|
OXFD
32
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $36.3M | 1.12% |
2,235,407
+200
| +0% | +$2.86K |
|
|
33
Replimune Group
REPL
$813M
| $35.3M | 1.09% |
+2,192,957
| New | +$38.4M |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| $33.2M | 1.02% |
2,993,565
+35,800
| +1% | +$445K |
|
35
Penumbra
PEN
$12.5B
| $32.5M | 1% |
217,129
+144,959
| +201% | +$20.3M |
|
|
36
Centene
CNC
$32.9B
| $32.1M | 0.99% |
443,490
-572,480
| -56% | -$39.7M |
|
|
GRTS
37
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $31.9M | 0.98% |
+2,242,636
| New | +$31.9M |
|
|
NUVA
38
DELISTED
NuVasive, Inc.
NUVA
| $31.2M | 0.96% |
+439,700
| New | +$28M |
|
39
CVS Health
CVS
$135B
| $31M | 0.95% |
+394,300
| New | +$28.2M |
|
|
CTLT
40
DELISTED
CATALENT, INC.
CTLT
| $30.5M | 0.94% |
668,850
+7,000
| +1% | +$296K |
|
|
CBIO
41
Crescent Biopharma
CBIO
$432M
| $29.5M | 0.91% |
20,481
+188
| +0.9% | +$284K |
|
42
Teladoc Health
TDOC
$1.75B
| $28.9M | 0.89% |
334,700
+103,700
| +45% | +$7.39M |
|
43
ProQR Therapeutics
PRQR
$250M
| $28.1M | 0.86% |
+1,450,925
| New | +$15.4M |
|
|
MOR
44
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $24M | 0.74% |
899,900
-369,900
| -29% | -$11.1M |
|
|
EPZM
45
DELISTED
Epizyme, Inc
EPZM
| $23.8M | 0.73% |
2,248,189
+226,800
| +11% | +$2.59M |
|
46
Zoetis
ZTS
$31.2B
| $23.2M | 0.71% |
253,300
+4,200
| +2% | +$373K |
|
|
LHCG
47
DELISTED
LHC Group LLC
LHCG
| $22.4M | 0.69% |
+217,480
| New | +$20.3M |
|
|
SYNH
48
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22.1M | 0.68% |
428,473
-553,200
| -56% | -$27.1M |
|
|
PRAH
49
DELISTED
PRA Health Sciences, Inc.
PRAH
| $22M | 0.68% |
+200,000
| New | +$20.8M |
|
50
Agilent Technologies
A
$38B
| $21.6M | 0.66% |
+306,400
| New | +$20.3M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO